Durvalumab(D) +/- tremelimumab(T) plus platinum-etoposide(EP) in 1L ES-SCLC: Characterization of long-term benefit in CASPIAN
Yazar
Trukhin, Dmytro
Saito, Haruhiro
Goldman, Jonathan W.
Garassino, Marina Chiara
Chen, Yuanbin
Reinmuth, Niels
Hotta, Katsuyuki
Poltoratskiy, Artem
Hochmair, Maximilian J.
ÖZGÜROĞLU, Mustafa
Ji, Jun Ho
Statsenko, Galina
Voitko, Oleksandr
Conev, Nikolay V.
Bondarenko, Igor
Spencer, Stuart
Xie, Mingchao
Jones, Stephanie
Franks, April
Shrestha, Yashaswi
Paz-Ares, Luis
Üst veri
Tüm öğe kaydını gösterKoleksiyonlar
- Makale [92796]